Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 56 Records) |
Query Trace: SLC22A2[original query] |
---|
Promoter region variation in NFE2L2 influences susceptibility to ototoxicity in patients exposed to high cumulative doses of cisplatin. The pharmacogenomics journal 2016 Jul . Spracklen T F, Vorster A A, Ramma L, Dalvie S, Ramesar R |
A Longitudinal HbA1c Model Elucidates Genes Linked to Disease Progression on Metformin. Clinical pharmacology and therapeutics 2016 Jul . Goswami Srijib, Yee Sook Wah, Xu Fei, Sridhar Sneha B, Mosley Jonathan Jd, Takahashi Atsushi, Kubo Michiaki, Maeda Shiro, Davis Robert L, Roden Dan M, Hedderson Monique M, Giacomini Kathleen M, Savic Radojka |
Pharmacogenomic Variants May Influence the Urinary Excretion of Novel Kidney Injury Biomarkers in Patients Receiving Cisplatin. International journal of molecular sciences 2017 Jun 18 (7): . Chang Cara, Hu Yichun, Hogan Susan L, Mercke Nickie, Gomez Madeleine, O'Bryant Cindy, Bowles Daniel W, George Blessy, Wen Xia, Aleksunes Lauren M, Joy Melanie |
Pharmacogenetics-based population pharmacokinetic analysis of gabapentin in patients with chronic pain: Effect of OCT2 and OCTN1 gene polymorphisms. Basic & clinical pharmacology & toxicology 2019 Mar 124 (3): 266-272. Yamamoto Priscila A, Benzi Jhohann R L, Azeredo Francine J, Dach Fabíola, Ianhez Júnior Edgar, Zanelli Cleslei F, de Moraes Natália |
Implication of critical pharmacokinetic gene variants on therapeutic response to metformin in Type 2 diabetes. Pharmacogenomics 2018 Jun . Phani Nagaraja M, Vohra Manik, Kakar Ananth, Adhikari Prabha, Nagri Shivashankara K, D'Souza Sydney C, Umakanth Shashikiran, Satyamoorthy Kapaettu, Rai Padmalatha |
SLC04A1, SLC22A2 and SLC28A2 variants not related to methotrexate efficacy or toxicity in rheumatoid arthritis patients. Pharmacogenomics 2018 Apr . Eektimmerman Frank, Swen Jesse J, Böhringer Stefan, Aslibekyan Stella, Allaart Cornelia F, Guchelaar Henk-J |
SLC22A2 variants and dolutegravir levels correlate with psychiatric symptoms in persons with HIV. The Journal of antimicrobial chemotherapy 2019 Apr 74 (4): 1035-1043. Borghetti A, Calcagno A, Lombardi F, Cusato J, Belmonti S, D'Avolio A, Ciccarelli N, La Monica S, Colafigli M, Delle Donne V, De Marco R, Tamburrini E, Visconti E, Di Perri G, De Luca A, Bonora S, Di Giambenedetto |
Genetic Variations and Cisplatin Nephrotoxicity: A Systematic Review. Frontiers in pharmacology 2018 10 9 1111. Zazuli Zulfan, Vijverberg Susanne, Slob Elise, Liu Geoffrey, Carleton Bruce, Veltman Joris, Baas Paul, Masereeuw Rosalinde, Maitland-van der Zee Anke-Hil |
Influence of pharmacogenetic polymorphisms and demographic variables on metformin pharmacokinetics in an admixed Brazilian cohort. British journal of clinical pharmacology 2018 Jan . Santoro Ana Beatriz, Botton Mariana Rodrigues, Struchiner Claudio José, Suarez-Kurtz Guilher |
A genome-wide association study on lipoprotein (a) levels and coronary artery disease severity in a Chinese population.
Journal of lipid research 2019 Jun . Liu Yibin, Ma Hongkun, Zhu Qian, Zhang Bin, Yan Hong, Li Hanping, Meng Jinxiu, Lai Weihua, Li Liwen, Yu Danqing, Zhong Shilo |
Outcome Definition Influences the Relationship Between Genetic Polymorphisms of ERCC1, ERCC2, SLC22A2 and Cisplatin Nephrotoxicity in Adult Testicular Cancer Patients. Genes 2019 May 10 (5): . Zazuli Zulfan, Otten Leila S, Drögemöller Britt I, Medeiros Mara, Monzon Jose G, Wright Galen E B, Kollmannsberger Christian K, Bedard Philippe L, Chen Zhuo, Gelmon Karen A, McGoldrick Nicole, Kitchlu Abhijat, Vijverberg Susanne J H, Masereeuw Rosalinde, Ross Colin J D, Liu Geoffrey, Carleton Bruce C, Maitland-van der Zee Anke |
Metformin Pharmacogenetics: Effects of SLC22A1, SLC22A2, and SLC22A3 Polymorphisms on Glycemic Control and HbA1c Levels. Journal of personalized medicine 2019 Mar 9 (1): . Al-Eitan Laith N, Almomani Basima A, Nassar Ahmad M, Elsaqa Barakat Z, Saadeh Nesreen |
Altered Glycemic Control Associated With Polymorphisms in the SLC22A1 (OCT1) Gene in a Mexican Population With Type 2 Diabetes Mellitus Treated With Metformin: A Cohort Study. Journal of clinical pharmacology 2019 Apr . Reséndiz-Abarca Carlos Alberto, Flores-Alfaro Eugenia, Suárez-Sánchez Fernando, Cruz Miguel, Valladares-Salgado Adán, Del Carmen Alarcón-Romero Luz, Vázquez-Moreno Miguel Alexander, Wacher-Rodarte Niels Agustín, Gómez-Zamudio Jaime Héct |
Effects of SLC22A2 (rs201919874) and SLC47A2 (rs138244461) genetic variants on Metformin Pharmacokinetics in Pakistani T2DM patients. JPMA. The Journal of the Pakistan Medical Association 2019 Feb 69 (2): 155-163. Moeez Sadaf, Khalid Zoya, Jalil Fazal, Irfan Muhammad, Ismail Muhammad, Arif Mohammad Ali, Niazi Rauf, Khalid Sumb |
Genetic variation of cisplatin-induced ototoxicity in non-cranial-irradiated pediatric patients using a candidate gene approach: The International PanCareLIFE Study. The pharmacogenomics journal 2019 Oct . Clemens Eva, Broer Linda, Langer Thorsten, Uitterlinden André G, de Vries Andrica C H, van Grotel Martine, Pluijm Saskia F M, Binder Harald, Byrne Julianne, Broeder Eline van Dulmen-den, Crocco Marco, Grabow Desiree, Kaatsch Peter, Kaiser Melanie, Kenborg Line, Winther Jeanette F, Rechnitzer Catherine, Hasle Henrik, Kepak Tomas, van der Kooi Anne-Lotte F, Kremer Leontien C, Kruseova Jarmila, Kuehni Claudia E, van der Pal Heleen, Parfitt Ross, Deuster Dirk, Matulat Peter, Spix Claudia, Tillmanns Amelie, Tissing Wim J E, Maier Lara, Am Zehnhoff-Dinnesen Antoinette, Zolk Oliver, van den Heuvel-Eibrink Marry M, |
Maternal-fetal genetic interactions, imprinting, and risk of placental abruption. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2020 9 35 (18): 3473-3482. Workalemahu Tsegaselassie, Enquobahrie Daniel A, Gelaye Bizu, Tadesse Mahlet G, Sanchez Sixto E, Tekola-Ayele Fasil, Hajat Anjum, Thornton Timothy A, Ananth Cande V, Williams Michelle |
Association of candidate pharmacogenetic markers with platinum-induced ototoxicity: PanCareLIFE dataset. Data in brief 2020 9 32 106227. Langer Thorsten, Clemens Eva, Broer Linda, Maier Lara, Uitterlinden André G, de Vries Andrica C H, van Grotel Martine, Pluijm Saskia F M, Binder Harald, Mayer Benjamin, von dem Knesebeck Annika, Byrne Julianne, van Dulmen-den Broeder Eline, Crocco Marco, Grabow Desiree, Kaatsch Peter, Kaiser Melanie, Spix Claudia, Kenborg Line, Winther Jeanette F, Rechnitzer Catherine, Hasle Henrik, Kepak Tomas, van der Kooi Anne-Lotte F, Kremer Leontien C, Kruseova Jarmila, Bielack Stefan, Sorg Benjamin, Hecker-Nolting Stefanie, Kuehni Claudia E, Ansari Marc, Kompis Martin, van der Pal Heleen J, Parfitt Ross, Deuster Dirk, Matulat Peter, Tillmanns Amelie, Tissing Wim J E, Beck Jörn D, Elsner Susanne, Am Zehnhoff-Dinnesen Antoinette, van den Heuvel-Eibrink Marry M, Zolk Oliver, |
Genetic variations in microRNA-binding sites of solute carrier transporter genes as predictors of clinical outcome in colorectal cancer. Carcinogenesis 2020 Dec . Bendova Petra, Pardini Barbara, Susova Simona, Rosendorf Jachym, Levy Miloslav, Skrobanek Pavel, Buchler Tomas, Kral Jan, Liska Vaclav, Vodickova Ludmila, Landi Stefano, Soucek Pavel, Naccarati Alessio, Vodicka Pavel, Vymetalkova Veroni |
Population pharmacokinetics of gabapentin in patients with neuropathic pain: Lack of effect of diabetes or glycaemic control. British journal of clinical pharmacology 2020 10 87 (4): 1981-1989. Costa Ana Carolina Conchon, de Lima Benzi Jhohann Richard, Yamamoto Priscila Akemi, de Freitas Maria Cristina Foss, de Paula Francisco José Albuquerque, Zanelli Cleslei Fernando, Lauretti Gabriela Rocha, de Moraes Natália Valadar |
Pharmacogenomics and functional imaging to predict irinotecan pharmacokinetics and pharmacodynamics: the predict IR study. Cancer chemotherapy and pharmacology 2021 Mar . Michael Michael, Liauw Winston, McLachlan Sue-Anne, Link Emma, Matera Annetta, Thompson Michael, Jefford Michael, Hicks Rod J, Cullinane Carleen, Hatzimihalis Athena, Campbell Ian G, Rowley Simone, Beale Phillip J, Karapetis Christos S, Price Timothy, Burge Mathew |
Effects of SLC22A2 808G>T polymorphism and bosutinib concentrations on serum creatinine in patients with chronic myeloid leukemia receiving bosutinib therapy. Scientific reports 2021 Mar 11 (1): 6362. Abumiya Maiko, Takahashi Naoto, Takahashi Saori, Yoshioka Tomoko, Kameoka Yoshihiro, Miura Masato |
Characterization of cytochrome P450 (CYP) 2D6 drugs as substrates of human organic cation transporters and multidrug and toxin extrusion proteins. British journal of pharmacology 2021 1 178 (6): 1459-1474. Neul Claudia, Hofmann Ute, Schaeffeler Elke, Winter Stefan, Klein Kathrin, Giacomini Kathleen M, Eichelbaum Michel, Schwab Matthias, Nies Anne |
The Association Between Genetic Polymorphisms of Transporter Genes and Prognosis of Platinum-Based Chemotherapy in Lung Cancer Patients. Pharmacogenomics and personalized medicine 2022 15 817-825. He Jia, Wang Zhan, Zou Ting, Wang Ying, Li Xiang-Ping, Chen Ju |
Pharmacokinetic and pharmacogenetic associations with dolutegravir neuropsychiatric adverse events in an African population. The Journal of antimicrobial chemotherapy 2022 8 77 (11): 3110-3117. Griesel Rulan, Sinxadi Phumla, Kawuma Aida, Joska John, Sokhela Simiso, Akpomiemie Godspower, Venter Francois, Denti Paolo, Haas David W, Maartens Ga |
Promoter haplotype structure of solute carrier 22 member 2 (SLC22A2) in the Xhosa population of South Africa and their differential effect on gene expression. Gene 2022 2 820 146292. Abrahams-October Zainonesa, Lloyd Sheridon, Pearce Brendon, Johnson Rabia, Benjeddou Mon |
Identification of sex-specific genetic associations in response to opioid analgesics in a White, non-Hispanic cohort from Southeast Minnesota. The pharmacogenomics journal 2022 Jan . Lopes Guilherme S, Lopes Jaime L, Bielinski Suzette J, Armasu Sebastian M, Zhu Ye, Cavanaugh Dana C, Moyer Ann M, Jacobson Debra J, Wang Liwei, Jiang Ruoxiang, St Sauver Jennifer L, Larson Nicholas |
Dolutegravir Discontinuation for Neuropsychiatric Symptoms in People Living with HIV and Their Outcomes after Treatment Change: A Pharmacogenetic Study. Metabolites 2022 12 12 (12): . Cusato Jessica, Borghetti Alberto, Teti Elisabetta, Milesi Maurizio, Tettoni Maria Cristina, Bonora Stefano, Trunfio Mattia, D'Avolio Antonio, Compagno Mirko, Di Giambenedetto Simona, Di Perri Giovanni, Calcagno Andr |
Association between organic cation transporter genetic polymorphisms and metformin response and intolerance in T2DM individuals: a systematic review and meta-analysis. Frontiers in public health 2023 8 11 1183879. Aiyu Peng, Chunmei Gong, Yuanfei Xu, Xiongshun Liang, Xiaoping Chen, Wenxu Hong, Junxia Y |
Identification of Transporter Polymorphisms Influencing Metformin Pharmacokinetics in Healthy Volunteers. Journal of personalized medicine 2023 3 13 (3): . Saiz-Rodríguez Miriam, Ochoa Dolores, Zubiaur Pablo, Navares-Gómez Marcos, Román Manuel, Camargo-Mamani Paola, Luquero-Bueno Sergio, Villapalos-García Gonzalo, Alcaraz Raquel, Mejía-Abril Gina, Santos-Mazo Estefanía, Abad-Santos Francis |
Impact of solute carrier transporter gene polymorphisms on serum creatinine concentrations in healthy volunteers. Pharmacology research & perspectives 2023 1 11 (1): e01048. Yokoyama Satoshi, Nakagawa Junichi, Kudo Masakiyo, Aiuchi Naoya, Seito Tatsuya, Isida Mizuri, Mikami Tatsuya, Ihara Kazushige, Nakaji Shigeyuki, Niioka Takeno |
- Page last reviewed:Feb 1, 2024
- Page last updated:Mar 25, 2024
- Content source: